Clinical Trial Update: Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating thalidomide in metastatic neuroendocrine tumors has completed, including gastrointestinal carcinoid tumors and pancreatic neuroendocrin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Carcinoid Tumor
• Pancreatic Neuroendocrine Tumor

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Gastrointestinal Carcinoid Tumor, Islet Cell Tumor | Phase 2 | Status: COMPLETED